This project is part of the EDCTP2 Programme supported by the European Union.

Happy New Year 2023

Dear Reader, On behalf of the SINDOFO Consortium, we wish you a happy, healthy and successful 2023. 2022 was an eventful year for the project with a lot of achievements


Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study

The Lancet infectious diseases

Peer reviewed article